May 2022 – Clinical Trial Results

Dr. Michael Mack and Dr. C. Michael Gibson discuss the STAR-T/D trials in which a column of microbeads attached to the bypass pump are used to remove ticagrelor, rivaroxaban, and apixaban

May 25, 2022

Disclosures: TBA

Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Non-LDL Lipid Lowering Targets for Event Reduction

May 13, 2022

Disclosures: TBA

Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Reimagining Prevention from a Public Healthcare Perspective

May 12, 2022

Disclosures: TBA

Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: The Verve Therapeutics Gene Editing Approach to Lowering LDL in Familial Hypercholesterolemia

May 10, 2022

Disclosures: TBA

Aspirin Therapy in 2022: New Horizons

May 2, 2022

A CME-Jointly Accredited Program This activity is supported by an independent educational grant from PLx Pharma Inc.